{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:19:54Z","timestamp":1788941994690,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"crossref","award":["LEUNG14GE0"],"award-info":[{"award-number":["LEUNG14GE0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CFF","award":["NARKEW07AB0"],"award-info":[{"award-number":["NARKEW07AB0"]}]}],"content-domain":{"domain":["clinicalkey.fr","cysticfibrosisjournal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jcf.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T16:16:47Z","timestamp":1509553007000},"page":"S50-S61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"S2","title":["Cystic Fibrosis-related cirrhosis"],"prefix":"10.1016","volume":"16","author":[{"given":"Daniel H.","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Narkewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2017.07.002_bb0005","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/0016-5085(93)91085-V","article-title":"Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells","volume":"105","author":"Cohn","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11894-004-0013-6","article-title":"Hepatobiliary complications of cystic fibrosis","volume":"6","author":"Feranchak","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jcf.2017.07.002_bb0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80166-4","article-title":"Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension","volume":"31","author":"Debray","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11894-010-0151-y","article-title":"Management of portal hypertension in children","volume":"13","author":"Mileti","year":"2011","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jcf.2017.07.002_bb0025","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cgh.2016.03.041","article-title":"Features of severe liver disease with portal hypertension in patients with cystic fibrosis","volume":"14","author":"Stonebraker","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0030","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0168-8278(99)80259-1","article-title":"Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study","volume":"30","author":"Durieu","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcf.2012.11.010","article-title":"Cirrhosis and other liver disease in cystic fibrosis","volume":"12","author":"Flass","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2017.07.002_bb0040","first-page":"S195","article-title":"Frequency and risk factors for variceal hemorrhage in CF Foundation registry patients with cystic fibrosis cirrhosis","volume":"63","author":"Wen Ye","year":"2016","journal-title":"J Pediatr Gastroenterol Hepatol Nutr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1399-3046.2010.01460.x","article-title":"Liver and combined lung and liver transplantation for cystic fibrosis: analysis of the UNOS database","volume":"15","author":"Arnon","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jcf.2017.07.002_bb0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1089-3261(05)70363-9","article-title":"Liver disease in cystic fibrosis","volume":"2","author":"Flora","year":"1998","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jcf.2017.07.002_bb0055","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/jmv.22048","article-title":"High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe","volume":"83","author":"Gobel","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0060","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jpeds.2015.06.062","article-title":"Baseline ultrasound and clinical correlates in children with cystic fibrosis","volume":"167","author":"Leung","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0065","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0070","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2004.08.006","article-title":"Epidemiology of liver disease in cystic fibrosis: a longitudinal study","volume":"41","author":"Lamireau","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0075","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/hep.510230652","article-title":"Biliary atresia: current concepts and research directions. Summary of a symposium","volume":"23","author":"Balistreri","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.cct.2012.11.005","article-title":"Incidence and clinical significance of elevated liver function tests in cystic fibrosis clinical trials","volume":"34","author":"Mayer-Hamblett","year":"2013","journal-title":"Contemp Clin Trials"},{"issue":"Suppl. 2","key":"10.1016\/j.jcf.2017.07.002_bb0085","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2017.07.002_bb0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cgh.2012.11.006","article-title":"Gastrointestinal complications of cystic fibrosis","volume":"11","author":"Gelfond","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0095","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/MPG.0b013e318258328d","article-title":"NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents","volume":"54","author":"Mack","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-2600(15)00545-7","article-title":"Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2\u20135years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study","volume":"4","author":"Davies","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2017.07.002_bb0105","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jama.2009.1295","article-title":"Genetic modifiers of liver disease in cystic fibrosis","volume":"302","author":"Bartlett","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jcf.2017.07.002_bb0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.nutr.27.061406.093625","article-title":"Cystic fibrosis and nutrition: linking phospholipids and essential fatty acids with thiol metabolism","volume":"28","author":"Innis","year":"2008","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2016.08.002","article-title":"Prevalence of elevated liver enzymes in children with cystic fibrosis diagnosed by newborn screen","volume":"16","author":"Woodruff","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2017.07.002_bb0120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bpg.2010.08.003","article-title":"Cystic fibrosis-associated liver disease","volume":"24","author":"Herrmann","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0125","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2009.12.052","article-title":"SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease","volume":"138","author":"Schwimmer","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0130","series-title":"Tietz textbook of clinical chemistry","year":"1994"},{"key":"10.1016\/j.jcf.2017.07.002_bb0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MPG.0000000000000758","article-title":"Increase of serum gamma-glutamyltransferase associated with development of cirrhotic cystic fibrosis liver disease","volume":"61","author":"Bodewes","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0140","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jpedsurg.2012.10.010","article-title":"Aspartate aminotransferase-to-platelet ratio index (APRi) in infants with biliary atresia: prognostic value at presentation","volume":"48","author":"Grieve","year":"2013","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jcf.2017.07.002_bb0145","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.28016","article-title":"Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease","volume":"62","author":"Leung","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0150","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/MPG.0b013e3181aed725","article-title":"Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis","volume":"50","author":"McGoogan","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MPG.0000000000000600","article-title":"Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis","volume":"60","author":"Cook","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0160","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jhep.2004.06.032","article-title":"Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease","volume":"41","author":"Pereira","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0165","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1542\/peds.18.3.387","article-title":"A distinctive type of biliary cirrhosis of the liver associated with cystic fibrosis of the pancreas; recognition through signs of portal hypertension","volume":"18","author":"Blanc","year":"1956","journal-title":"Pediatrics"},{"issue":"Pt 2","key":"10.1016\/j.jcf.2017.07.002_bb0170","first-page":"357","article-title":"Cystic fibrosis in adults: an autopsy study","volume":"14","author":"Vawter","year":"1979","journal-title":"Pathol Annu"},{"key":"10.1016\/j.jcf.2017.07.002_bb0175","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jgh.13045","article-title":"Predict esophageal varices via routine trans-abdominal ultrasound: a design of classification analysis model","volume":"31","author":"Zhang","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0180","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jmri.22580","article-title":"Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy","volume":"34","author":"Reeder","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jcf.2017.07.002_bb0185","series-title":"Clinical research workshop","author":"National Institutes of Health\/Cystic Fibrosis Foundation","year":"2009"},{"key":"10.1016\/j.jcf.2017.07.002_bb0190","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0195","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/hep.24212","article-title":"Cystic fibrosis-cirrhosis, portal hypertension, and liver biopsy: reply","volume":"53","author":"Lewindon","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0200","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/PAP.0b013e31825c6a20","article-title":"Liver biopsy in modern clinical practice: a pediatric point-of-view","volume":"19","author":"Ovchinsky","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hep.24014","article-title":"Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy","volume":"53","author":"Lewindon","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0210","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gut.2006.115410","article-title":"The incidence and risks of liver biopsy in non-cirrhotic patients: an evaluation of 3806 biopsies","volume":"56","author":"Huang","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jcf.2017.07.002_bb0215","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/jhep.2001.0103303le01","article-title":"The risks of percutaneous liver biopsy","volume":"33","author":"Falck-Ytter","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MPG.0b013e318249c12a","article-title":"Evaluation of risk factors for bleeding after liver biopsy in children","volume":"55","author":"Westheim","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0225","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1319-3767.91735","article-title":"Outpatient blind percutaneous liver biopsy in infants and children: is it safe?","volume":"18","author":"El-Shabrawi","year":"2012","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0230","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/BF02079063","article-title":"Complications of percutaneous liver biopsy in infants and children","volume":"154","author":"Lachaux","year":"1995","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0235","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bpg.2005.11.006","article-title":"Cystic fibrosis: nutritional consequences and management","volume":"20","author":"Dodge","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0240","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.vaccine.2012.12.004","article-title":"Vaccine induced hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease","volume":"31","author":"Shapiro","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jcf.2017.07.002_bb0245","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.23539","article-title":"The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations","volume":"14","author":"Imani","year":"2014","journal-title":"Hepat Mon"},{"issue":"Suppl. 1","key":"10.1016\/j.jcf.2017.07.002_bb0250","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S2210-7401(12)70015-3","article-title":"Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action","volume":"36","author":"Poupon","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000222.pub3","article-title":"Ursodeoxycholic acid for cystic fibrosis-related liver disease","author":"Cheng","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2017.07.002_bb0260","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/hep.510230627","article-title":"Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis","volume":"23","author":"Colombo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0265","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00004836-200104000-00009","article-title":"Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease","volume":"32","author":"Nousia-Arvanitakis","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0270","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2036.2012.05177.x","article-title":"Ursodeoxycholic acid therapy in cystic fibrosis liver disease\u2014a retrospective long-term follow-up case-control study","volume":"36","author":"Kappler","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcf.2017.07.002_bb0275","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.dld.2009.07.022","article-title":"Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease","volume":"42","author":"Siano","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jcf.2017.07.002_bb0280","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/ajg.2011.156","article-title":"High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"106","author":"Eaton","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0285","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0290","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MCP.0b013e3282f10a16","article-title":"Liver disease in cystic fibrosis","volume":"13","author":"Colombo","year":"2007","journal-title":"Curr Opin Pulm Med"},{"issue":"Suppl. 1","key":"10.1016\/j.jcf.2017.07.002_bb0295","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005176-199900001-00001","article-title":"Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group","volume":"28","author":"Sokol","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0300","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpeds.2016.05.008","article-title":"Long-term ursodeoxycholic acid therapy does not alter lithocholic acid levels in patients with cystic fibrosis with associated liver disease","volume":"177","author":"Colombo","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0305","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0310","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/hep.28153","article-title":"Primary prophylaxis of variceal bleeding in children and the role of MesoRex bypass: summary of the Baveno VI Pediatric Satellite Symposium","volume":"63","author":"Shneider","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0315","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0320","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International Liver Transplant Society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.jcf.2017.07.002_bb0325","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2147\/VHRM.S3608","article-title":"Current concepts in the management of hepatopulmonary syndrome","volume":"4","author":"Ho","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.jcf.2017.07.002_bb0330","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.chest.2015.10.040","article-title":"Hepatopulmonary syndrome in patients with cystic fibrosis and liver disease","volume":"149","author":"Breuer","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2017.07.002_bb0335","doi-asserted-by":"crossref","first-page":"47","DOI":"10.14218\/JCTH.2015.00044","article-title":"Hepatopulmonary syndrome and liver transplantation: a recent review of the literature","volume":"4","author":"Cosarderelioglu","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0340","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0345","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0272-5231(05)70305-1","article-title":"Mediators, cytokines, and growth factors in liver-lung interactions","volume":"17","author":"Panos","year":"1996","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jcf.2017.07.002_bb0350","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.giec.2015.03.001","article-title":"The role of medical therapy for variceal bleeding","volume":"25","author":"Bhutta","year":"2015","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"10.1016\/j.jcf.2017.07.002_bb0355","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1399-3046.2012.01652.x","article-title":"Portal hypertension in children: expert pediatric opinion on the report of the Baveno v consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"16","author":"Shneider","year":"2012","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jcf.2017.07.002_bb0360","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0365","first-page":"1111","article-title":"Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results","volume":"50","author":"Pozler","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jcf.2017.07.002_bb0370","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s10620-015-3968-2","article-title":"Cystic fibrosis associated with worse survival after liver transplantation","volume":"61","author":"Black","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcf.2017.07.002_bb0375","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/lt.22240","article-title":"Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data","volume":"17","author":"Mendizabal","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jcf.2017.07.002_bb0380","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00063198-200111000-00014","article-title":"Liver transplantation in cystic fibrosis","volume":"7","author":"Genyk","year":"2001","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jcf.2017.07.002_bb0385","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1432-2277.2006.00344.x","article-title":"Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry","volume":"19","author":"Melzi","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.jcf.2017.07.002_bb0390","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.transproceed.2012.02.033","article-title":"Survival of cystic fibrosis patients undergoing liver and liver-lung transplantations","volume":"45","author":"Desai","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jcf.2017.07.002_bb0395","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/petr.12057","article-title":"Liver transplantation in cystic fibrosis: a report from Baylor College of Medicine and the Texas Children's Hospital","volume":"17","author":"Harring","year":"2013","journal-title":"Pediatr Transplant"},{"issue":"Suppl. 1","key":"10.1016\/j.jcf.2017.07.002_bb0400","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/01.mpg.0000226390.02355.52","article-title":"Liver disease in cystic fibrosis","volume":"43","author":"Colombo","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0405","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-6143.2007.02028.x","article-title":"Cystic fibrosis liver disease: to transplant or not to transplant?","volume":"8","author":"Nash","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcf.2017.07.002_bb0410","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/lt.23389","article-title":"Pulmonary function in individuals who underwent liver transplantation: from the US cystic fibrosis foundation registry","volume":"18","author":"Miller","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jcf.2017.07.002_bb0415","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1432-2277.2004.00013.x","article-title":"Effects of liver transplantation on the nutritional status of patients with cystic fibrosis","volume":"18","author":"Colombo","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.jcf.2017.07.002_bb0420","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1399-3046.2010.01341.x","article-title":"Isolated liver transplantation in children with cystic fibrosis\u2014an Australian experience","volume":"14","author":"Nightingale","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jcf.2017.07.002_bb0425","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jcf.2013.12.010","article-title":"Simultaneous liver-pancreas transplantation for cystic fibrosis-related liver disease: a multicenter experience","volume":"13","author":"Bandsma","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2017.07.002_bb0430","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/ajt.13630","article-title":"Under utilization of pancreas transplants in cystic fibrosis recipients in the United Network Organ Sharing (UNOS) data 1987\u20132014","volume":"16","author":"Usatin","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcf.2017.07.002_bb0435","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MPG.0b013e3181ecf3d4","article-title":"Biomarkers in nonalcoholic fatty liver disease: a new era in diagnosis and staging of disease in children","volume":"51","author":"Feldstein","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0440","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MPG.0b013e31825bb01a","article-title":"Identification of serum protein biomarkers in biliary atresia by mass spectrometry and ELISA","volume":"55","author":"Song","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0445","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.trsl.2010.05.008","article-title":"Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease","volume":"156","author":"Nobili","year":"2010","journal-title":"Transl Res"},{"key":"10.1016\/j.jcf.2017.07.002_bb0450","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00005176-200411000-00017","article-title":"Association of serum interleukin-8 levels with the degree of fibrosis in infants with chronic liver disease","volume":"39","author":"Nobili","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2017.07.002_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","author":"Fickert","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcf.2017.07.002_bb0460","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clinre.2016.09.006","article-title":"Obeticholic acid in primary biliary cholangitis","volume":"41","author":"Erlinger","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199317308172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199317308172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T17:23:14Z","timestamp":1693156994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199317308172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":92,"alternative-id":["S1569199317308172"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2017.07.002","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic Fibrosis-related cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}